Publication: Optimising strategies for Plasmodium falciparum Malaria elimination in Cambodia: Primaquine, mass drug administration and Artemisinin resistance
Issued Date
2012-05-25
Resource Type
ISSN
19326203
Other identifier(s)
2-s2.0-84861472663
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
PLoS ONE. Vol.7, No.5 (2012)
Suggested Citation
Richard J. Maude, Duong Socheat, Chea Nguon, Preap Saroth, Prak Dara, Guoqiao Li, Jianping Song, Shunmay Yeung, Arjen M. Dondorp, Nicholas P. Day, Nicholas J. White, Lisa J. White Optimising strategies for Plasmodium falciparum Malaria elimination in Cambodia: Primaquine, mass drug administration and Artemisinin resistance. PLoS ONE. Vol.7, No.5 (2012). doi:10.1371/journal.pone.0037166 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/13453
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Optimising strategies for Plasmodium falciparum Malaria elimination in Cambodia: Primaquine, mass drug administration and Artemisinin resistance
Other Contributor(s)
Abstract
Background: Malaria elimination requires a variety of approaches individually optimized for different transmission settings. A recent field study in an area of low seasonal transmission in South West Cambodia demonstrated dramatic reductions in malaria parasite prevalence following both mass drug administration (MDA) and high treatment coverage of symptomatic patients with artemisinin-piperaquine plus primaquine. This study employed multiple combined strategies and it was unclear what contribution each made to the reductions in malaria. Method and Findings: A mathematical model fitted to the trial results was used to assess the effects of the various components of these interventions, design optimal elimination strategies, and explore their interactions with artemisinin resistance, which has recently been discovered in Western Cambodia. The modelling indicated that most of the initial reduction of P. falciparum malaria resulted from MDA with artemisinin-piperaquine. The subsequent continued decline and near elimination resulted mainly from high coverage with artemisinin-piperaquine treatment. Both these strategies were more effective with the addition of primaquine. MDA with artemisinin combination therapy (ACT) increased the proportion of artemisinin resistant infections, although much less than treatment of symptomatic cases with ACT, and this increase was slowed by adding primaquine. Artemisinin resistance reduced the effectiveness of interventions using ACT when the prevalence of resistance was very high. The main results were robust to assumptions about primaquine action, and immunity. Conclusions: The key messages of these modelling results for policy makers were: high coverage with ACT treatment can produce a long-term reduction in malaria whereas the impact of MDA is generally only short-term; primaquine enhances the effect of ACT in eliminating malaria and reduces the increase in proportion of artemisinin resistant infections; parasite prevalence is a better surveillance measure for elimination programmes than numbers of symptomatic cases; combinations of interventions are most effective and sustained efforts are crucial for successful elimination. © 2012 Maude et al.